• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Af­ter in­vest­ing in their Se­ries B, Lil­ly bags a li­cense for a batch of meta­bol­ic can­di­dates

4 years ago
Deals

CVS takes a swing at Bris­tol My­ers and Pfiz­er, ex­clud­ing cov­er­age of their megablock­buster Eliquis in 2022

4 years ago
Pharma

The lat­est health­care SPAC comes in at $200M with a laser fo­cus on ar­ti­fi­cial in­tel­li­gence

4 years ago
Financing
AI

Roche of­fers an up­beat two-plus-year look at its an­ti-TIG­IT com­bo ther­a­py — but will two deaths hurt its chances?

4 years ago
R&D

Dekkers-found­ed in­vest­ment firm No­valis Life­Sciences rais­es $300M for sec­ond fund and adds to the team

4 years ago
Financing

Over­sight Com­mit­tee un­leash­es scathing drug pric­ing re­port as Sen­ate preps to vote on al­low­ing Medicare ne­go­ti­a­tions

4 years ago
Pharma

As Bio­haven CEO Coric preps FDA fil­ing for new mi­graine spray, he's al­ready scout­ing for celebri­ty spokesper­son

4 years ago
Pharma
Marketing

Mod­er­na says its mR­NA flu vac­cine cleared ear­ly stud­ies, but com­par­isons with oth­er vac­cines dri­ve stock down

4 years ago
R&D

Covid-19 roundup: UK preps for a wave of Omi­cron cas­es; Bourla sug­gests a fourth dose might be nec­es­sary

4 years ago
Coronavirus

Snakebit An­gion re­ports an­oth­er miss for lead pro­gram, as biotech pre­pares to shift its 'pri­ma­ry fo­cus'

4 years ago
R&D

Bil­lion­aire BioN­Tech back­ers have been kick­ing the tires at No­var­tis' big gener­ics arm — re­port

4 years ago
Deals
Bioregnum

Flag­ship on cen­ter stage: Ax­cel­la’s new CMO likens the biotech to ‘pro­fes­sion­al sports team’; Life af­ter the ...

4 years ago
Peer Review

Glax­o­SmithK­line en­list­ed Har­ris Poll for a se­vere asth­ma sur­vey — re­sults point to more out­reach

4 years ago
Pharma
Marketing

Vi­a­tris and Bio­con mull pool­ing their biosim­i­lars in­to a $10B stand­alone com­pa­ny — re­port

4 years ago
Deals

Kenya to re­duce im­port de­pen­den­cy with pro­duc­tion of new site; Co-lab­o­ra­to­ry space to open in Chi­na

4 years ago
Manufacturing

Re­call re­port: San­doz yanks 1 lot of enoxa­parin af­ter ex­po­sure to warm tem­per­a­tures

4 years ago
Manufacturing

Ever op­ti­mistic de­spite con­cerns, Brain­Storm teams with Catal­ent to prep for pos­si­ble ap­proval for ALS drug

4 years ago
Cell/Gene Tx
Manufacturing

Fu­ji­film cracks open doors at its newest drug pro­duc­tion site in the Nether­lands

4 years ago
Manufacturing

Taipei's Bo­ra wants in on the CD­MO game as re­port shows plen­ty of room for in­dus­try growth

4 years ago
Cell/Gene Tx
Manufacturing

Mer­ck en­lists Ther­mo Fish­er to make Covid-19 an­tivi­ral mol­nupi­ravir for Cana­da, UK

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Co­v­ax, In­di­an man­u­fac­tur­er at odds over vac­cine sup­ply; EU plan­ning sur­plus on shot ...

4 years ago
Coronavirus
Manufacturing

To­tus pulls in $40M Se­ries A with sights on PI3Kα; FDA asks Sesen for an­oth­er tri­al af­ter CRL, biotech says

4 years ago
News Briefing

Eir Ven­tures tops up life sci­ences fund with $138M for Nordic biotechs

4 years ago
Financing

With new piv­otal da­ta, uniQure and CSL Behring dash to the FDA with a po­ten­tial block­buster gene ther­a­py for ...

4 years ago
R&D
Cell/Gene Tx
First page Previous page 611612613614615616617 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times